ArticleJournal of autoimmunity2021

Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.

Ana I Rodriguez-Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.